en

PRODUCT DETAIL

MIDZA 100 mg filmom obalené tablety

Code 7088C
MA number 21/0069/18-S
Product Form: tbl flm 56x100 mg (blis.PVC/PVD/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX18 Lacosamide
Shelf life: 30
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 20.02.2018
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_MIDZA_11.2022.pdf  
SPC: SPC_MIDZA_ 11.2022.pdf  
Safety feature Yes
Data update: 23.06.2022
eu-flag.png sk-flag.png